UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

The New England journal of medicine, 2019-10, Vol.381 (17), p.1632-1643

2019

Volltextzugriff (PDF)

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Clinical cancer research, 2023-01, Vol.29 (1), p.110-121

2023

Volltextzugriff (PDF)

Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine

European journal of clinical pharmacology, 2019-09, Vol.75 (9), p.1309-1318

2019

Volltextzugriff (PDF)

First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

British journal of cancer, 2022-04, Vol.126 (7), p.1010-1017

2022

Volltextzugriff (PDF)

Individualized Pazopanib Dosing: A Prospective Feasibility Study in Cancer Patients

Clinical cancer research, 2016-12, Vol.22 (23), p.5738-5746

2016

Volltextzugriff (PDF)

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?

Frontiers in oncology, 2022-09, Vol.12, p.940582-940582

2022

Volltextzugriff (PDF)

Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer

BMC cancer, 2022-03, Vol.22 (1), p.228-228, Article 228

2022

Volltextzugriff (PDF)

Framework for Implementing Individualised Dosing of Anti-Cancer Drugs in Routine Care: Overcoming the Logistical Challenges

Cancers, 2023-06, Vol.15 (13), p.3293

2023

Volltextzugriff (PDF)

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer

British journal of cancer, 2020-04, Vol.122 (8), p.1166-1174

2020

Volltextzugriff (PDF)

Hypertension and Rarefaction during Treatment with Telatinib, a Small Molecule Angiogenesis Inhibitor

Clinical cancer research, 2008-06, Vol.14 (11), p.3470-3476

2008

Volltextzugriff (PDF)

Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors

Supportive care in cancer, 2022-03, Vol.30 (3), p.2307-2315

2022

Volltextzugriff (PDF)

Referral patterns of GIST patients: data from a nationwide study

Acta oncologica, 2024-02, Vol.63 (1), p.28-34

2024

Volltextzugriff (PDF)

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients

Biomedicine & pharmacotherapy, 2023-07, Vol.163, p.114823-114823, Article 114823

2023

Volltextzugriff (PDF)

Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study

Therapeutic drug monitoring, 2019-10, Vol.41 (5), p.561-567

2019

Volltextzugriff (PDF)

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer

Cancer chemotherapy and pharmacology, 2020-05, Vol.85 (5), p.917-930

2020

Volltextzugriff (PDF)

Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments

Annals of surgical oncology, 2007-02, Vol.14 (2), p.942-953

2007

Volltextzugriff (PDF)

RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics

Cancers, 2020-05, Vol.12 (6), p.1372

2020

Volltextzugriff (PDF)

Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data

Supportive care in cancer, 2022-06, Vol.30 (6), p.5137-5146

2022

Volltextzugriff (PDF)

Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels

BMC cancer, 2018-12, Vol.18 (1), p.1200-1200, Article 1200

2018

Volltextzugriff (PDF)

Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature

Cancers, 2022-04, Vol.14 (7), p.1832

2022

Volltextzugriff (PDF)

Neoadjuvant Systemic Treatment of Primary Angiosarcoma

Cancers, 2020-08, Vol.12 (8), p.2251

2020

Volltextzugriff (PDF)

Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors

Journal of clinical oncology, 2009-10, Vol.27 (30), p.5094-5101

2009

Volltextzugriff (PDF)

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study

ESMO open, 2020-08, Vol.5 (4), p.e000787, Article e000787

2020

Volltextzugriff (PDF)

1 – 25 von 99

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(97)
Mit Volltextzugriff
(93)

Publikationsform

Artikel
(99)

Sprache

Englisch
(99)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Encorafenib, Binimetinib, and Cetuximab in BRAF V600E–Mutated Colorectal Cancer

Combination of the STING Agonist MIW815 (ADU-S100) and PD-1 Inhibitor Spartalizumab in Advanced/Metastatic Solid Tumors or Lymphomas: An Open-Label, Multicenter, Phase Ib Study

Individualized dosing of oral targeted therapies in oncology is crucial in the era of precision medicine

First-in-human phase 1 dose-escalation study of CAN04, a first-in-class interleukin-1 receptor accessory protein (IL1RAP) antibody in patients with solid tumours

Individualized Pazopanib Dosing: A Prospective Feasibility Study in Cancer Patients

Beta-adrenergic receptor blockade in angiosarcoma: Which beta-blocker to choose?

Exposure-response analyses of cabozantinib in patients with metastatic renal cell cancer

Targeted Next Generation Sequencing as a Reliable Diagnostic Assay for the Detection of Somatic Mutations in Tumours Using Minimal DNA Amounts from Formalin Fixed Paraffin Embedded Material

Framework for Implementing Individualised Dosing of Anti-Cancer Drugs in Routine Care: Overcoming the Logistical Challenges

Phase 1 study of the pan-HER inhibitor dacomitinib plus the MEK1/2 inhibitor PD-0325901 in patients with KRAS-mutation-positive colorectal, non-small-cell lung and pancreatic cancer

Hypertension and Rarefaction during Treatment with Telatinib, a Small Molecule Angiogenesis Inhibitor

Taste, smell and mouthfeel disturbances in patients with gastrointestinal stromal tumors treated with tyrosine-kinase inhibitors

Referral patterns of GIST patients: data from a nationwide study

Design and statistics of pharmacokinetic drug-drug, herb-drug, and food-drug interaction studies in oncology patients

Therapeutic Drug Monitoring of Oral Anticancer Drugs: The Dutch Pharmacology Oncology Group-Therapeutic Drug Monitoring Protocol for a Prospective Study

Phase I study of lapatinib plus trametinib in patients with KRAS-mutant colorectal, non-small cell lung, and pancreatic cancer

Small molecule tyrosine kinase inhibitors in the treatment of solid tumors: an update of recent developments

RNA-Sequencing of Tumor-Educated Platelets, a Novel Biomarker for Blood-Based Sarcoma Diagnostics

Symptoms reported by gastrointestinal stromal tumour (GIST) patients on imatinib treatment: combining questionnaire and forum data

Harnessing soft tissue sarcoma with low-dose pazopanib - a matter of blood levels

Health-Related Quality of Life and Side Effects in Gastrointestinal Stromal Tumor (GIST) Patients Treated with Tyrosine Kinase Inhibitors: A Systematic Review of the Literature

Neoadjuvant Systemic Treatment of Primary Angiosarcoma

Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol

Phase I Pharmacokinetic and Pharmacodynamic Study of the Aurora Kinase Inhibitor Danusertib in Patients With Advanced or Metastatic Solid Tumors

Evaluation of the use and efficacy of (neo)adjuvant chemotherapy in angiosarcoma: a multicentre study

Aktive Filter

Suchergebnisse filtern